Mantle Cell Lymphoma (MCL) Not Yet Recruiting Phase 2 Trials for Bortezomib (DB00188)

Also known as: Lymphoma, Mantle-Cell / Mantle Cell Lymphoma / Mantle-Cell Lymphoma / Lymphoma, Mantle- Cell / Lymphoma, Mantle Cell / Mantle-Cell Lymphomas / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS / Mantle cell lymphomas

DBCOND0071979 (Mantle Cell Lymphoma (MCL))Not Yet Recruiting2 IdentifierTitlePurposeDrugs
NCT03016988The Efficacy and Safety of Bortezomib Combined With Fludarabine and Cytarabine Treatment for Mantle Cell LymphomaTreatment